The mTOR inhibitor temsirolimus added to rituximab combined with dexamethasone, cytarabine, and cisplatinum (R-DHAP) for the treatment of patients with relapsed or refractory DLBCL...
by Witzens-Harig, Mathias (Author)
, Viardot, Andreas (Author)
, Keller, Ulrich (Author)
, Wosniok, Julia (Author)
, Deuster, Oliver (Author)
, Klemmer, Jennifer (Author)
, Geueke, Anne-Marie (Author)
, Meißner, Julia (Author)
, Ho, Anthony Dick (Author)
, Atta, Johannes (Author)
, Marks, Reinhard (Author)
, La Rosée, Paul (Author)
, Buske, Christian (Author)
, Dreyling, Martin H. (Author)
, Hess, Georg (Author)
,
Call Number:
Loading…
Located:
Loading…
Article (Journal)
Online Resource